Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Plasma Adiponectin ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Frontiers in Endocrinology ◽

10.3389/fendo.2020.00288 ◽

2020 ◽

Vol 11 ◽

Author(s):

Fang Zhang ◽

Shishi Xu ◽

Lizhi Tang ◽

Xiaohui Pan ◽

Nanwei Tong

Keyword(s):

Systematic Review ◽

Weight Loss ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Glucose Lowering ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Diabetes Therapy ◽

10.1007/s13300-019-0668-5 ◽

2019 ◽

Vol 10 (5) ◽

pp. 1879-1892 ◽

Cited By ~ 3

Author(s):

Qing Chen ◽

Ting Liu ◽

Haonan Zhou ◽

Huawei Peng ◽

Caifeng Yan

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Inhibitor Treatment

Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trials

Acta Diabetologica ◽

10.1007/s00592-020-01479-8 ◽

2020 ◽

Vol 57 (6) ◽

pp. 689-696 ◽

Cited By ~ 1

Author(s):

Ilaria Dicembrini ◽

Besmir Nreu ◽

Chiara Montereggi ◽

Edoardo Mannucci ◽

Matteo Monami

Keyword(s):

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Risk Of Cancer

Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.107981 ◽

2020 ◽

Vol 159 ◽

pp. 107981 ◽

Cited By ~ 4

Author(s):

Ilaria Dicembrini ◽

Chiara Montereggi ◽

Besmir Nreu ◽

Edoardo Mannucci ◽

Matteo Monami

Keyword(s):

Pancreatic Cancer ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Bullous pemphigoid and dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized controlled trials

Endocrine ◽

10.1007/s12020-020-02272-x ◽

2020 ◽

Vol 69 (3) ◽

pp. 504-507 ◽

Cited By ~ 2

Author(s):

Giovanni Antonio Silverii ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Chiara Montereggi ◽

Edoardo Mannucci ◽

...

Keyword(s):

Bullous Pemphigoid ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01380.x ◽

2011 ◽

Vol 13 (7) ◽

pp. 594-603 ◽

Cited By ~ 68

Author(s):

K. Esposito ◽

D. Cozzolino ◽

G. Bellastella ◽

M. I. Maiorino ◽

P. Chiodini ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Hba1c Target

Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

10.37766/inplasy2021.12.0113 ◽

2021 ◽

Author(s):

Shangyu Chai ◽

◽

Ruya Zhang ◽

Ye Zhang ◽

Richard David Carr ◽

...

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Glycemic Variability ◽

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Cardiovascular events and all-cause mortality in patients with type 2 diabetes TREATED with DIPEPTIDYL PEPTIDASE-4 inhibitors: An EXTENSIVE meta-analysis of randomized controlled trials

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2021.06.002 ◽

2021 ◽

Author(s):

Edoardo Mannucci ◽

Besmir Nreu ◽

Chiara Montereggi ◽

Benedetta Ragghianti ◽

Marco Gallo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Events ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

All Cause Mortality

A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials

Diabetes Obesity and Metabolism ◽

10.1111/dom.13135 ◽

2018 ◽

Vol 20 ◽

pp. 34-46 ◽

Cited By ~ 28

Author(s):

Carolyn F. Deacon

Keyword(s):

Dipeptidyl Peptidase ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽

Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Diabetes Metabolic Syndrome and Obesity Targets and Therapy ◽

10.2147/dmso.s202024 ◽

2019 ◽

Vol Volume 12 ◽

pp. 1513-1526 ◽

Cited By ~ 4

Author(s):

Na Wang ◽

Tao Yang ◽

Jie Li ◽

Xianfeng Zhang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Meta Analysis ◽

Controlled Trials ◽

Dipeptidyl Peptidase 4 ◽

Randomized Controlled ◽